COVID-19 vaccine: WHO okays J&J s jab for emergency use
It is the third COVID-19 vaccine after the two-shot regimens of Pfizer-BioNTech and AstraZeneca to receive backing from the WHO, and the first requiring just a single injection
Reuters | March 13, 2021 | Updated 10:05 IST
COVAX, co-run with the Gavi vaccine alliance, has an agreement for more than 500 million doses of the J&J vaccine, Aylward said
The World Health Organization on Friday approved the emergency listing of Johnson & Johnson s COVID-19 vaccine, giving its seal of approval to expedite use especially in countries with weaker regulatory agencies. It is the third COVID-19 vaccine after the two-shot regimens of Pfizer-BioNTech and AstraZeneca to receive backing from the WHO, and the first requiring just a single injection.